Table 3:

Descriptions of priority-need interventions

InterventionDescription
Permanent supportive housing
  • Long-term housing in the community with no set preconditions for access. Housing may be paired with the provision of individualized supportive services that are tailored to participants’ needs and choices, including assertive community treatment and intensive case management.

  • This guideline groups the Housing First model (a homeless assistance approach that prioritizes providing housing) with permanent supportive housing.

Income assistance
  • Benefits and programs that improve socioeconomic status. This may include assistance that directly increases income and programs that help with cost reduction of basic living necessities.

  • This guideline also groups employment programs (e.g., individual placement and support, and compensated work therapy) in this category.

Case management
  • Standard case management allows for the provision of an array of social, health care and other services with the goal of helping the client maintain good health and social relationships.

  • Intensive case management offers the support of a case manager who brokers access to an array of services. Case-management support can be available for up to 12 hours per day, 7 days a week, and each case manager often has a caseload of 15–20 service users.

  • Assertive community treatment offers team-based care to individuals with severe and persistent mental illness by a multidisciplinary group of health care workers in the community. This team should be available 24 hours per day, 7 days per week.

  • Critical time intervention supports continuity of care for service users during times of transition. Case management is administered by a critical time intervention worker and is a time-limited service, usually lasting 6–9 months.

Pharmacologic interventions for substance use disorder
  • Pharmacologic interventions for opioid use disorder, including methadone, buprenorphine, diacetylmorphine, levo-α-acetylmethadol and naltrexone.

  • Pharmacologic agents for reversal of opioid overdose: opioid antagonist administered intravenously or intranasally (e.g., naloxone).

Harm reduction for substance use disorders
  • Supervised consumption facilities: facilities (stand-alone, co-located or pop-up) where people who use substances can consume preobtained substances under supervision.

  • Managed alcohol programs: shelter, medical assistance, social services and the provision of regulated alcohol to support residents with severe alcohol use disorder.